Oxford BioMedica PLC buy melinda
Start price
22.09.10
/
50%
€3.00
Target price
22.03.11
€4.50
Performance (%)
-41.67%
End price
22.03.11
€1.75
Summary
This prediction ended on 22.03.11 with a price of €1.75. The BUY prediction by melinda for Oxford BioMedica PLC performed very badly with a performance of -41.67%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Oxford BioMedica PLC | 0.719% | 0.719% | 41.129% | 67.464% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by melinda for this prediction
In the thread Oxford BioMedica PLC diskutieren
Biopharma-
Oxford BioMedica ist ein biopharmazeutisches Unternehmen in der Entwicklung und Kommerzialisierung von innovativen Gen-basierter Medikamente spezialisiert
(Laufzeit überschritten)